share_log

Those Who Invested in Option Care Health (NASDAQ:OPCH) Five Years Ago Are up 74%

Those Who Invested in Option Care Health (NASDAQ:OPCH) Five Years Ago Are up 74%

五年前投資option care health(納斯達克:OPCH)的人現在盈利74%
Simply Wall St ·  11/12 21:47

It hasn't been the best quarter for Option Care Health, Inc. (NASDAQ:OPCH) shareholders, since the share price has fallen 25% in that time. On the bright side the share price is up over the last half decade. However we are not very impressed because the share price is only up 74%, less than the market return of 108%.

Option Care Health Inc. (NASDAQ:OPCH) 股東們並沒有度過最好的一個季度,因爲股價在這段時間內下跌了25%。 但好消息是,在過去的五年中,股價已經上漲。 然而,我們並不是很滿意,因爲股價僅上漲了74%,低於市場回報率的108%。

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

鑑於此,值得看看該公司的基本面是否一直是長期業績的驅動因素,或者是否存在一些不一致之處。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

市場有時無疑是高效的,但價格並不總是反映基礎業務表現。 一種檢查市場情緒如何隨時間改變的方法是查看公司的股價與每股收益(EPS)之間的互動。

During the five years of share price growth, Option Care Health moved from a loss to profitability. That's generally thought to be a genuine positive, so investors may expect to see an increasing share price. Given that the company made a profit three years ago, but not five years ago, it is worth looking at the share price returns over the last three years, too. In fact, the Option Care Health stock price is 15% lower in the last three years. During the same period, EPS grew by 39% each year. It would appear there's a real mismatch between the increasing EPS and the share price, which has declined -5% a year for three years.

在股價增長的五年中,Option Care Health 從虧損轉爲盈利。 這通常被認爲是一個真正的積極因素,因此投資者可能期望看到股價上漲。 鑑於該公司三年前盈利,但五年前沒有盈利,因此值得再看看過去三年的股價回報率。 實際上,過去三年裏 Option Care Health 股價下跌了15%。 在同一期間,每年 EPS 增長了39%。 似乎 EPS 的增長與股價之間存在真正的不匹配,過去三年股價年均下跌了-5%。

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

下圖顯示了EPS隨時間的變化情況(如果您單擊該圖像,則可以查看更多詳細信息)。

big
NasdaqGS:OPCH Earnings Per Share Growth November 12th 2024
納斯達克GS:option care health每股收益增長2024年11月12日

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

我們認爲內部人士在過去一年中進行了重大購買是積極的。話雖如此,大多數人認爲盈利和收入增長趨勢更能成爲業務的有意義指南。在購買或出售股票之前,我們始終建議仔細審查歷史增長趨勢,在此查看。

A Different Perspective

另一種看法

Investors in Option Care Health had a tough year, with a total loss of 20%, against a market gain of about 39%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 12% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Option Care Health better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Option Care Health you should know about.

投資option care health的投資者在過去一年遭遇了困難,全年虧損20%,而市場則上漲了約39%。然而,請記住,即使是最好的股票有時也會在十二個月的時間內表現不佳。 在積極的一面,長期股東已經賺錢,過去半個十年每年增長12%。也許最近的拋售是一個機會,因此值得查看基本數據,以尋找長期增長趨勢的跡象。 跟蹤股價表現長期來看總是很有趣。但要更好地了解option care health,我們需要考慮許多其他因素。請考慮風險,例如。每家公司都有風險,而且我們已經發現2個option care health的警告信號,你應該知道。

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

還有很多其他的公司,公司的內部人士正在購買股票。你可能不想錯過這個免費的小市值公司的低估列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論